These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 5667086)

  • 1. Investigation on the mechanism of action of cytotoxic hexitols. II. The effect on the nucleic acid content of bone marrow in rats.
    Jeney A; Szabó J; Vály-Nagy T
    Neoplasma; 1968; 15(3):237-40. PubMed ID: 5667086
    [No Abstract]   [Full Text] [Related]  

  • 2. Investigations on the mechanism of action of cytotoxic hexitols. I. Cross-resistance investigations on Yoshida sarcoma tumour.
    Jeney A; Szabó J; Vályi-Nagy T
    Neoplasma; 1968; 15(3):231-5. PubMed ID: 5667085
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of mannitol-myleran and two new dibromo-hexitols on the metabolic activities of nucleic acids and proteins. I.
    Hidvégi EJ; Lónai P; Holland J; Antoni F; Institoris L; Horváth IP
    Biochem Pharmacol; 1967 Nov; 16(11):2143-53. PubMed ID: 6076607
    [No Abstract]   [Full Text] [Related]  

  • 4. Investigation on the mode of action of the cytotoxic hexitols. 3. Pharmacobiochemical studies with Degranol.
    Jeney A; Vályi-Nagy T; Szabó J; Szabó I
    Neoplasma; 1969; 16(2):151-9. PubMed ID: 5807550
    [No Abstract]   [Full Text] [Related]  

  • 5. Investigation on the mode of action of cytotoxic hexitols V. Pharmaco-biochemical studies with dibromomannitol.
    Szabŏ J; Jeney A; Darŏcy A; Institoris L; Nosztray K; Vályi-Nagy T
    Neoplasma; 1973; 20(1):13-25. PubMed ID: 4702202
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of antitumour agents: Degranol, Mannitol-myleran, Dibromomannitol and Dibromodulcitol on cell morphology in tissue cultures.
    Pályi I
    Neoplasma; 1967; 14(2):159-66. PubMed ID: 6047728
    [No Abstract]   [Full Text] [Related]  

  • 7. The immune-suppressive effect of myelobromol and degranol on staphylococci-infected mice.
    Iván E; Hernádi F; Biró L
    Jpn J Exp Med; 1971 Apr; 41(2):113-6. PubMed ID: 5313763
    [No Abstract]   [Full Text] [Related]  

  • 8. Bone marrow cell proliferation after busulphan treatment and its relation to humoral control mechanisms.
    Niskanen E
    Acta Pathol Microbiol Scand; 1967; 70():Suppl 190:1-93. PubMed ID: 5603197
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of mannitol or furosemide diuresis on cis-dichlorodiammineplatinum(II) antitumor activity and toxicity to host-renewing cell populations in rats.
    Pera MF; Harder HC
    Cancer Res; 1979 Apr; 39(4):1279-86. PubMed ID: 421211
    [No Abstract]   [Full Text] [Related]  

  • 10. [Study of the nucleic acid and glycogen content of postmortem bone marrow cells].
    Kiseleva MV
    Probl Gematol Pereliv Krovi; 1968 Jun; 13(6):49-51. PubMed ID: 5736868
    [No Abstract]   [Full Text] [Related]  

  • 11. Experimental study of the combined effect of leukeran, degranol and predisolone.
    Stukov AN
    Neoplasma; 1975; 22(2):181-4. PubMed ID: 1161113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Measurement of nucleic acid of the bone marrow by fluorimetry].
    Li GL; Yin SN; Geng TB; Liang YX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1983 Oct; 5(5):311-4. PubMed ID: 6203659
    [No Abstract]   [Full Text] [Related]  

  • 13. Toxicity, haematological effects and anti-tumour activity of epoxides derived from disubstituted hexitols. Mode of action of mannitol myleran and dibromomannitol.
    Elson LA; Jarman M; Ross WC
    Eur J Cancer (1965); 1968 Dec; 4(6):617-25. PubMed ID: 5717958
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of alloxan diabetes in staphylococcal infection in mice].
    Iván E; Gábor R; Hernádi F
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Nov; (11):109-12. PubMed ID: 4454833
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of mannitol mustard (NSC-9698) on nuclear DNA content and birefringence of Hela and Chinese hamster cells.
    Pályi I; Gyeskó A; Sugár J
    Cancer Chemother Rep; 1969 Apr; 53(2):115-20. PubMed ID: 5799416
    [No Abstract]   [Full Text] [Related]  

  • 16. Changes in erythropoietin pharmacokinetics following busulfan-induced bone marrow ablation in sheep: evidence for bone marrow as a major erythropoietin elimination pathway.
    Chapel S; Veng-Pedersen P; Hohl RJ; Schmidt RL; McGuire EM; Widness JA
    J Pharmacol Exp Ther; 2001 Aug; 298(2):820-4. PubMed ID: 11454947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the development of bone marrow hypoplasia. 3. Some biochemical aspects.
    Das KC; Sen NN; Aikat BK
    Indian J Med Res; 1969 Apr; 57(4):688-98. PubMed ID: 5306673
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of cytostatic alkylating agents on deoxyribonucleo protein complex of lymphatic and haemopoetic tissue.
    Matyásová J; Skalka M
    Neoplasma; 1966; 13(4):433-42. PubMed ID: 5921852
    [No Abstract]   [Full Text] [Related]  

  • 19. [Dynamics of nucleic acid metabolism in the bone marrow and liver of rats exposed to the combined action of external gamma radiation and plutonium-239].
    Elkina NI
    Radiobiologiia; 1984; 24(3):370-3. PubMed ID: 6204355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Development and new trends in drug research].
    Vályi-Nagy T
    Acta Pharm Hung; 1968 Jun; 38(2):49-57. PubMed ID: 4972740
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.